• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION CAROTID WALLSTENT; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION CAROTID WALLSTENT; STENT, CAROTID Back to Search Results
Model Number 26605
Device Problems Positioning Failure (1158); Mechanical Problem (1384); Defective Device (2588); Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/28/2022
Event Type  malfunction  
Event Description
It was reported that the stent was not fully resconstrained.The 80% stenosed target lesion was located in the moderately tortuous and mildy calcified common carotid artery.A 10.0-24 carotid wallstent was advanced for treatment.However, the stent was unable to release.When the stent was about to remove, it was not fully reconstrained.The device was removed carefully and slowly.Another carotid wallstent monorail 10.0-24 was deployed but still the sent was unable to release and it was not fully resconstrained prior to removal.The device was also removed carefully and slowly, and it seems that the device was damaged.The procedure was completed with another of same device.No patient complications were reported and the patient was stable.
 
Manufacturer Narrative
B5.Describe event or problem- updated.
 
Event Description
It was reported that the stent was not fully reconstrained.The 80% stenosed target lesion was located in the moderately tortuous and mildy calcified common carotid artery.A 10.0-24 carotid wallstent was advanced for treatment.However, the stent was unable to release.When the stent was about to remove, it was not fully reconstrained.The device was removed carefully and slowly.Another carotid wallstent monorail 10.0-24 was deployed but still the stent was unable to release and it was not fully reconstrained prior to removal.The device was also removed carefully and slowly, and it seems that the device was damaged.The procedure was completed with another of same device.No patient complications were reported and the patient was stable.It was further reported that the target lesion was not calcified and the stents were deployed by following the normal operation steps.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAROTID WALLSTENT
Type of Device
STENT, CAROTID
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key14521707
MDR Text Key292796317
Report Number2134265-2022-05903
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeTW
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/27/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number26605
Device Catalogue Number26605
Device Lot Number0026692928
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/27/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/25/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-